Currently, the KPO market size is estimated to be about $5.5 billion and the sector is growing by about 15-17 per cent, dominated by professionals belonging to fields such as management, medical and engineering, the chamber said.
Participants include over 750 delegates and 400 companies. The event is expected to attract about 5,000 business visitors
The first COVID-19 vaccine shots in India were given on Saturday to nearly two lakh frontline healthcare and sanitary workers as Prime Minister Narendra Modi rolled out the world's largest inoculation drive against the pandemic that has caused 1,52,093 deaths and upended millions of lives in the country.
Ranbaxy, which ranks second in domestic sales among drug companies (it is the largest in total sales), has announced plans to be the market leader in the next few years.
India is in the midst of its biggest crisis since Independence. It is a national emergency and begs to be dealt with. Politics can wait. Lives need to be saved. We need to vaccinate India at a pace faster than any country in the world, asserts Ramesh Menon.
To this end, the state has roped in Ernst & Young (E&Y) to prepare a master plan. E&Y outbid KPMG to win the Rs 1.65 crore (Rs 16.5-million) contract from Maharashtra Industrial Development Corporation.
The current testing norms to rule out harmful effects of genetically modified crops like Bt-brinjal are far from being fool proof, a member of biotech regulator GEAC said.
Indian cricket captain Mahendra Singh Dhoni has sent a legal notice to a Chennai-based healthcare company for allegedly defaulting payment of his brand endorsement fees.
'Even after vaccines are given, precautions like using a mask and maintaining social distancing have to be taken.'
'We must not compromise with the standard, the quality. We don't need to be the first to launch a drug but what we need is a Made in India vaccine that the entire world can rely on'
'Our government's claim that there are no undetected cases of infection that happened within our bustling cities because of exposure to infected international travellers are not credible,' notes Rahul Jacob.
The vaccine candidate, ZyCoV-D, showed a "strong immune response" in animal studies, and the antibodies produced were able to completely neutralise the wild type virus, Zydus said. The 12 institutes have been asked by the ICMR to fast track clinical trials of the vaccine as it is being considered as one of the top priority projects which are being monitored at the topmost level of the government.
Lenders say settlements will cross over 100 accounts in the March quarter.
A quiet but determined battle is being fought in the courts, and outside, by US agricultural biotech giant Monsanto, its Indian affiliates and seed lobbyists to free the prices of genetically modified Bt cotton from state government control.
The Biocon chairman said there is a regulatory path for GM crops which aims to establish safety and efficacy over an accepted period and it has been diligently followed by Bt brinjal on the basis of which the Genetic Engineering Approval Committee has given its positive verdict.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
Gates, who is to attend the World Economic Forum's Annual Meeting, on Monday said there is reason to be optimistic than ever about the future progress using vaccines to give all children a healthy start to life.
Amid a raging debate over release of Bt brinjal for commercial use, Science and Technology Minister Prithviraj Chavan on Tuesday said genetically-tweaked variety of the vegetable was 'safe for all'.
The top 200 companies were picked from over 12,000 publicly-listed firms with sales of less than $1 billion in the Asia-Pacific region.
Year 2008 results of India's largest drug maker, Ranbaxy Laboratories, and Wockhardt were also impacted by forex losses. Companies such as Aurobindo and Orchid are also expected to post forex losses, say analysts.
Allahabad Agriculture Institute's admission announcement for undergraduate, postgraduate and diploma programmes for 2008.
'Modi forgot to ask Trump for anything that India may need -- and there is so much shortfall all around!', states Ambassador M K Bhadrakumar.
Sun Pharma has evinced its interest in buying Hyderabad-based biotech company Zenotech Laboratories, through an open offer to buy 28.1 per cent worth Rs 18.41 crore ($3 million).
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
The Aditya Birla Group has received in-principle approval from the Kerala government to set up a Rs 4,000-crore (Rs 40 billion) IT and Biotech Knowledge Park and a branch of Birla Institute of Technology and Sciences (BITS) at Kozhikode.
Test marketing of bio beer was done some two years ago and there was tremendous response in several places, Dr B Srinivas Amarnath of Advaith Biotech Bangalore, who produced it after several years of research, said in Puducherry on Saturday launching the beverage in the burgeoning beer market of Puducherry.
With nearly two decades as a professor in several American cities and now the owner of two biotech companies, one in San Antonio and the other in the Bay Area, Masarrat Ali could have started his political career with some style. But he chose last year to be a foot soldier, running a precinct for Barack Obama in San Antonio.
New drug discovery and contract research have taken a back seat as global drug majors have slowed down their research and development offshoring to India.
Eagle Seeds & Biotech limited, Indore, require trainees for the accounts department.
Minority shareholders of Hyderabad-based Zenotech Laboratories, a biotech company in which Ranbaxy owns 46.8 per cent, are up in arms against Ranbaxy's new owner Daiichi Sankyo for allegedly failing to buy additional shares at the price offered by the former promoters of Ranbaxy.
Dr Reddy's Laboratories, Nicholas Piramal and other Indian drug makers are relying on niche and smaller value, acquisition strategy for growth owing to global slowdown and failure of big-ticket acquisitions in the past.
According to Amitabh Arora, chief representative, Think London, "The agency will help Indian companies enter business agreements with 100-odd biotech and pharma companies and about 50 contract research organisations based in London besides arranging private equity from London-based PE firms.
Mukesh Ambani's privately held biotech research company, Reliance Life Sciences, will soon diversify to take up biofuel production in a major way. Industry sources said the facilities might require an investment of Rs 150-200 crore (Rs 1.5 billion to Rs 2 billion). One hectare of land yields about a tonne of crop, so RLS will need to cultivate about one lakh hectares of land, they say. The majority of investments go into sourcing raw material, they say.
University of Madras offers many programmes from the Department of Zoology. "How to Apply" details found inside.
Companies like Shanta Biotech, Panacea Biotec and Serum Institute of India are among the leading vaccine makers which have not been able to file any fresh application to the WHO due to this temporary de-recognition of the country's drug regulatory system. The WHO pre-qualification is essential for companies to supply vaccines to national immunisation programmes funded by the WHO or UNICEF outside the country.
ABRPL is working on developing drugs for anaemia, cancer and arthritis, said Bruce Murdoch, chief business officer, Avesthagen. "We are targeting high-end products that are going off-patent and are not working on popular soon-to-be off-patent biotech molecules. We should be able to bring a couple of molecules into the commercialisation stage next year," he said.
Is it possible to extend lifespans to, say, 120 years, or longer, asks Devangshu Datta.
Efforts by Indian activists to challenge the Biotechnology Regulatory Authority Bill, now pending in Parliament, may get a boost from a controversy that has broken out in the US
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
Avista helped some companies restructure their debt in such a way that overseas investors had to take a steep haircut
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances